Loading...

PLX PROTALIX BIOTHERAPEUTICS INC Management Changes 8-K Filing

PRTL

PLX

PROTALIX BIOTHERAPEUTICS INC

(PLX)

2025 8-K

Show Summary

Summary

Financial Statements

Financial Results

Bylaw Amendments

Stockholder Update

Financial Results

Clinical Trial Update

Financial Results

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Condition and Oth...

Financial Results Announcement

Agreement for Stock Sale

Financial Results Announcement

Regulation FD Disclosure

External Links:

On April 21, 2025, Eyal Rubin, CFO of Protalix BioTherapeutics, announced his resignation effective in six months to pursue other opportunities, during which he will continue with his current role and receive full salary and benefits. He will also receive a severance payment and accelerated vesting of equity incentives upon departure.

AI Assistant

PROTALIX BIOTHERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.